Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Voprosy Meditsinskoi Khimii|November 5, 1999
[Aminopeptidases in human leukemia cells]T A Gureeva, N V Golubeva, O N LubkovaVoprosy Meditsinskoi Khimii|September 1, 1990
[Contribution of lysosomal enzymes into degradation of short- and long-lived proteins in human embryonal fibroblasts with abnormal chromosome complement]N V Golubeva, O V Podobed, V I Kukharenko, et al.Voprosy Meditsinskoi Khimii|May 1, 1994
[A comparative study of aspartyl and cysteine proteinases and their inhibitors in human B- and T-cell leukemias]T A Gureeva, N V Golubeva, O N Lubkova, et al.Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|May 1, 1988
[Kinetics of protein degradation in diploid and trisomic human fibroblasts]O V Podobed, N V Golubeva, V I Kukharenko, et al.Biulleten' Eksperimental'Noi Biologii I Meditsiny|June 1, 1987
[Inactivation of blood plasma alpha 1-proteinase inhibitor as affected by 2 splenic thiol proteinases active in a neutral medium]L A Lokshina, N V Golubeva, F S Baranova, et al.Meditsina Truda I Promyshlennaia Ekologiia|September 29, 2006
[Immune state of arterial hypertension and hypercholesterolemia patients engaged into construction materials production]Iu V Romanova, E N Lekhanova, A A Buganov, et al.Bulletin of Experimental Biology and Medicine|July 23, 2008
Damage and activation of endothelial cells during in vitro hypoxiaO A Antonova, S A Loktionova, N V Golubeva, et al.Biokhimiia (Moscow, Russia)|July 1, 1993
[Proteolytic enzymes in human lymphocytic leukemia cells. II. Comparative characteristics of proteolytic enzymes and their inhibitors in three differing types of lymphoid cells]T A Gureeva, N V Golubeva, V S Bylinkina, et al.Biulleten' Eksperimental'Noi Biologii I Meditsiny|October 1, 1983
[Immunochemical study of bovine spleen thiol proteinases: cathepsinS B, H and L]L A Lokshina, I A Tarkhanova, O N Lubkova, et al.Kardiologiia|February 12, 2008
[Von Willebrand factor and soluble P-selectin in patients with non ST-Elevation acute coronary syndrome during treatment with glycoprotein IIb/IIIa antagonist eptifibatide]A A Mazaev, Ia A Naĭmushin, S G Khaspekova, et al.Pageof 3